Sopharma Trading AD, a leading player in the pharmaceutical distribution sector, is headquartered in Bulgaria (BG) and operates extensively across Southeast Europe. Founded in 1998, the company has established itself as a trusted partner in the healthcare industry, focusing on the distribution of pharmaceuticals, medical devices, and healthcare products. With a commitment to quality and innovation, Sopharma Trading AD offers a diverse portfolio of core services, including logistics, marketing, and sales support for healthcare providers. The company is recognised for its robust supply chain management and customer-centric approach, ensuring timely delivery of essential medical products. Sopharma Trading AD has achieved significant milestones, positioning itself as a market leader in Bulgaria and the surrounding regions. Its dedication to excellence and strategic partnerships has earned the company a reputation for reliability and efficiency in the pharmaceutical landscape.
How does Sopharma Trading AD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sopharma Trading AD's score of 16 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sopharma Trading AD, headquartered in Bulgaria (BG), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Sopharma AD, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Sopharma Trading AD, it is important to note that emissions data may be inherited from its parent company, Sopharma AD. This relationship could potentially provide insights into broader corporate sustainability initiatives and climate strategies. As of now, Sopharma Trading AD has not established specific science-based targets (SBTi) or other reduction initiatives. The lack of available data suggests that the company may still be in the early stages of developing its climate commitments or reporting frameworks. In summary, Sopharma Trading AD's current climate impact remains unclear due to the absence of emissions data and defined reduction targets, but its affiliation with Sopharma AD may play a role in shaping its future sustainability efforts.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sopharma Trading AD is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.